Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

11 Dec 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/reverse-reverse-liver-disease-biotech-hepion-and-pharma-two-b-call-merger

05 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/05/2992326/0/en/Pharma-Two-B-Announces-Poster-Presentation-on-P2B001-at-the-Annual-Meeting-of-the-Parkinson-s-Disease-Study-Group.html

11 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/11/2978264/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Effectiveness-of-Registration-Statement-Related-to-Proposed-Merger.html

04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940630/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Filing-of-Registration-Statement-on-Form-F-4-Related-to-Proposed-Merger.html

15 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/15/2516777/0/en/Pharma-Two-B-Presents-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-the-MDS-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html

05 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/05/2416529/0/en/Pharma-Two-B-Presents-Late-Breaker-Abstract-on-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-American-Academy-of-Neurology-AAN-Annual-Meeting.html
ABOUT THIS PAGE